NCAM1 and acute myeloid leukemia: However, according to the results of our previous (35) and current study comparing the number of CD3+CD56+ T lymphocytes with varying WBC counts, no explanation has been reached concerning the compensated CD3+CD56+ T lymphocyte number in AML-1 and ALL-2 patients only.